Precision Medicine

KēlaHealth Lands $12.9M to Expand AI-Powered Surgical Intelligence Platform

  • by

What You Should Know: –  KēlaHealth announced their Series A round (combined seed and Series A) of $12.9M led by Sante Ventures and new innovation VC, Intuitive Ventures. – KēlaHealth, is a surgical intelligence engine that applies a dynamic cycle of patient-specific predictions, stratified interventions,… Read More »KēlaHealth Lands $12.9M to Expand AI-Powered Surgical Intelligence Platform

AWS, PHDA Collaborate to Develop Breast Cancer Screening and Depression Machine Learning Models

  • by

What You Should Know: – Amazon Web Services (AWS) and the Pittsburgh Health Data Alliance (PHDA) announce a collaboration to produce more accurate machine learning models for breast cancer screening and depression. – In work funded through the PHDA-AWS collaboration, a research team led by… Read More »AWS, PHDA Collaborate to Develop Breast Cancer Screening and Depression Machine Learning Models

AstraZeneca Collaborates with RenalytixAI to Develop Precision Medicine for Chronic Diseases

  • by

Shots: The two companies will develop and launch precision medicine strategies for CV, renal, and metabolic diseases. The first stage in the collaboration will use KidneyIntelX to improve outcomes for patients with CKD and its complications, in coordination with the Mount Sinai Health System The… Read More »AstraZeneca Collaborates with RenalytixAI to Develop Precision Medicine for Chronic Diseases

FDA, Syapse Expand Research to Generate Real-World Data Related to COVID-19 and Cancer

  • by

What You Should Know: The FDA and Syapse announce research collaboration expansion to address urgent public health challenges including supporting FDA’s goal of rapid understanding of COVID-19. As part of the research, Syapse is partnering with FDA’s Oncology Center of Excellence to investigate methods to… Read More »FDA, Syapse Expand Research to Generate Real-World Data Related to COVID-19 and Cancer

Founders’ story: Seven Bridges

  • by

A Q&A with executives from Seven Bridges, a bioinformatics analysis business, highlights the company’s work in the precision medicine sector.

Empowering Patients to Advance Precision Medicine, One EHR at a Time

Electronic health record (EHR) systems store incredibly rich data about individual patients, but historically, individuals have been unable to access this information easily and share it for research. However, use of patients’ data could accelerate scientific discovery and progress toward precision medicine. Permitting patients to… Read More »Empowering Patients to Advance Precision Medicine, One EHR at a Time